Keywords: schering-plough/centocor, revise, remicade, golimumab, deals, usa-based, schering-plough

Schering-Plough/Centocor revise Remicade and golimumab deals

Article | 07 January 2008

USA-based Schering-Plough and Centocor have revised their 1998 distribution agreement on Remicade (infliximab for chronic inflammatory disorders and golimumab, Centocor's next ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Schering Plough

Schering-Plough

Go to company listing

Related Drugs

Infliximab

Remicade

Alpha

Prolastin

Go to drug listing